Neoplasia/BPH

	Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer. Eur Urol Oncol Lijnen RAG, Ringia JB, Claps F, Vogel WV, Boellaard TN, van Rhijn BWG, Braat AJAT, Mertens LS. PMID: 41794597 [PubMed - as supplied by publisher]
	Unraveling the connection between PFOA and bladder cancer: A study integrating network toxicology, molecular docking, and experimental validation. Toxicol Appl Pharmacol Yan H, Yin C, Xu F, Li R. PMID: 41794187 [PubMed - as supplied by publisher]
	Adequate Tissue Submission from Transurethral Resection Specimens for Detecting Incidental Prostate Carcinoma: Diagnostic Accuracy and Cassette Utilization in Thailand. Asian Pac J Cancer Prev Chaijitrawan P, Sammor A, Warnnissorn N, Pisutpunya A, Atiroj N, Yawatta M, Vanichakarn D. PMID: 41793690 [PubMed - in process]
	Diagnostic Value of Rabbit-Derived 47 kDa Epitope-Based Antibodies as a Detection and Evaluation Method for Bladder Cancer. Asian Pac J Cancer Prev Nur Budaya T, Seputra KP, Susianti H, Aditya Hutama S, Wilianto B, Amanda C. PMID: 41793669 [PubMed - indexed for MEDLINE]
	Breath Aldehyde Profiling using PFBHA-GC/MS as a Prostate Cancer Biomarker. Asian Pac J Cancer Prev Sasaki Y, Matsumura T, Shitanaka Y, Urita Y. PMID: 41793654 [PubMed - indexed for MEDLINE]
	Survival outcomes after surgical treatment for non-clear cell renal cell carcinoma with tumor thrombus extension: a population-based cohort study. World J Urol Cheaib JG, Rivera López CA, Cronin C, Alshak MN, El-Achkar A, Patel SH, Singla N. PMID: 41793499 [PubMed - indexed for MEDLINE]
	Frailty and frailty progression in relation to the risk of benign prostatic hyperplasia/lower urinary tract symptoms among Chinese middle-aged and older men: a prospective cohort study. Aging Male Li L, Dong A, Liu K, Wu Y, Gong Y. PMID: 41793280 [PubMed - indexed for MEDLINE]
	Sarcomatoid Renal Cell Carcinoma: Biological Features and Therapeutic Implications-A Narrative Review. Curr Urol Rep Lasorsa F, Milella M, Rutigliano M, di Bari A, d'Amati A, Pandolfo SD, Bignante G, Caniglia A, Autorino R, Ditonno P, Lucarelli G. PMID: 41792526 [PubMed - in process]
	Natural history of untreated prostate cancer: a comprehensive review of long-term progression patterns and survival outcomes. Prostate Cancer Prostatic Dis Tewari AK, Mehrazin R, Wiklund P, DeMeo M, Kaplan SA, Te AE. PMID: 41792475 [PubMed - as supplied by publisher]
	Predictors of Residual Tumour in Non-Muscle-Invasive Bladder Cancer Following Repeat Transurethral Resection: A Meta-Analysis. J Coll Physicians Surg Pak Li J, He Y, Wu S. PMID: 41792072 [PubMed - indexed for MEDLINE]
	Accuracy of diagnostic codes to identify metastatic prostate cancer in medicare claims database. Cancer Epidemiol Zhou B, Raval AD, Zhang Y, Sambamoorthi N, Sambamoorthi U. PMID: 41791349 [PubMed - as supplied by publisher]
	Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts. JCO Glob Oncol Harris W, Shirley S, Liow E, Tan A, Jacobs C, Fong P, Fu S, Tan E, Waldron N, Weickhardt A, Wong S, Tran B, Lawrence N. PMID: 41791014 [PubMed - indexed for MEDLINE]
	Virtual Versus In-Person Visits in Prostate Cancer: Communication and Patient-Reported Outcomes From a Prospective Observational Study in Jordan. JCO Glob Oncol Abaza H, Alzibdeh A, Khanfar A, Al-Ibraheem A, Khader J, Al-Sayed M, Almousa A, Mohamad I, Abuhijla F, Abdel-Razeq H, Al-Omari A, Abu-Hijlih R. PMID: 41791012 [PubMed - indexed for MEDLINE]
	Application and efficacy of the pubovesical complex-preserving technique in intrafascial laparoscopic radical prostatectomy: A propensity score-matched analysis. PLoS One Zhu Z, Zhu Y, Wu H, Zhou P, Liu Q, Tong J, Wang Y. PMID: 41790723 [PubMed - indexed for MEDLINE]
	Incidental renal pelvis and ureteral verrucous carcinoma: A case report and literature review. Medicine (Baltimore) Yang Z, Liu Y, Zhang X, Song L, Jiang J, Pan J, Li J, Li J. PMID: 41790656 [PubMed - indexed for MEDLINE]
	Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival. JAMA Netw Open Büttner T, Klümper N, Ellinger J, Ritter M, Krausewitz P. PMID: 41790469 [PubMed - indexed for MEDLINE]
	Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology. Discov Oncol Guo A, Lu Y, Wang J, Jia Z, Yang J, Ning X. PMID: 41790354 [PubMed - as supplied by publisher]
	Assessment of radiotherapy effect and toxicity using tissue-associated DNA methylation markers in cell-free DNA: a study on prostate cancer. Radiat Environ Biophys Bahtiyar N, Mermut O, Firtina S, Ozaydin A, Suleymanova A, Isikgil B, Onaran . PMID: 41790195 [PubMed - as supplied by publisher]
	Dynamic Profiling of Circulating Tumor Cells and MYC/PTEN Alterations in Prostate Cancer Patients Undergoing Radical Prostatectomy in Amazon Population. Mol Carcinog Chaves JR, Burbano RMR, Cohen-Paes AN, Alcântara DDFÁ, de Souza APB, Gomes MJN, Ramos SAA, Khayat AS. PMID: 41789775 [PubMed - as supplied by publisher]
	Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions. Curr Opin Oncol Shi X, Rifai S, Meher Z, Hussain A. PMID: 41789650 [PubMed - as supplied by publisher]

Articles 1 - 20 / 186083

Page 1 of 9305



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy